Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl-Propofol-EMLA/LMX4 for Bone Marrow Aspiration
NCT00187135Phase 3Terminated
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Mar 2002
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fentanyl (transdermal patch + oral transmucosal lozenge) in procedural pain (3 arms), sponsored by St. Jude Children's Research Hospital. Primary endpoint: Pain (Yes/No). Started Mar 2002; status: terminated.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT00187135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00187135.